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It has been well documented that a massive release of not only glutamate but also other neurotransmitters 
may modulate the final responses of nerve cells to the ischemic neuronal injury， But there is no information 
regarding whether the release of monoamines is directly associated with synaptic vesicular proteins under 
ischemia， In the present study， it was investigated whether synapsin 1， syntaxin and SNAP-25 are involved 
in the release of 5-hydroxytryptamine (eH]5-HT) in glucosejoxygen deprived (GOD) rat hippocampal 
slices. And， the effect of NMDA receptor using DL-2-amino-5-phosphonovaleric acid (APV) on ischemia­
induced release of 5-HT and the changes of the above proteins were also investigated. GOD for 20 minutes 
enhanced release of eH]5-HT， which was in part blocked by the NMDA receptor antagonist， APV. The 
augmented expression of synapsin 1 during GOD for 20 minutes， which was also in part prevented by 
APV. In contrast， the expression of syntaxin and SNAP-25 were not altered during GOD. These results 
suggest that ischemic insult induces release of eH]5-HT associated with synapsin 1， synaptic vesicular 
protein， via activation of NMDA receptor in part. 
Key Words: Hippocampal slices， Glucosejoxygen deprivation， 5-Hydroxytryptamine， Synapsin， Syntaxin， 
SNAP-25 
INTRODUCTION 
Brain tissues have high energy demand requiring a 
constant and unimpeded supply of oxygen and sub­
strate (Siesjö， 1984). Ischemia is conveniently defined 
as a reduction in cerebral blood flow of sufficient 
severity to cause functional or metabolic deficits， or 
overt brain damage (Siesjö et al， 1998). The primary 
effects of ischemia are reduced supply of substrate for 
energy metabolism (oxygen and glucose) and cause 
neuronal and glial death direct1y. These primary 
abnormalities and after reperfusion can also trigger 
secondary processes leading to cell death in regions 
of incomplete ischemia (Sharp et al， 1998). Secondary 
effects of ischemia in the brain include release of 
neurotransmitters， calcium influx into cells， activation 
Corresponding to: KyungEun Lee， Department of Pharmacology， 
College of Medicine， Ewha Womans University， 911-1 Mok-6-
dong， Yangcheon-gu， Seoul 158-710， Korea. (Tel) 82-2-650-5744， 
(Fax) 82-2-653-5076， (E-mail) kelee@mm.ewha.ac.kr 
347 
of protease and lipases， production of free radicals 
and proinflammatory molecules， activation of intra­
cellular second messengers， and induction of genes 
that promote cell death via apoptosis (Sharp et al， 
1998). 
It is well-known that glutamate is released during 
ischemia (Benveniste et al， 1984; Globus et al， 1988a) 
and several other neurotransmitters appear simul 
taneously in the extracellular space; y-aminobutyric 
acid (GABA) (Globus et al， 1988b; Phillis et al， 
1994)， dopamine (Globus et al， 1989; Phebus & 
Clements， 1989)， 5-hydroxytrγptamine (5-HT) (Baker 
et al， 1991; Prehen et al， 1991)， glycine (Korf et al， 
1988; Hillered et al， 1989)， norepinephrine (Globus et 
al， 1989) and acetylcholine (Bertrand et al， 1993; 
Ishimura et al， 1994). It has been well documented 
that a massive release of not only glutamate but also 
other neurotransmitters may modulate the final re­
sponses of nerve cells to the ischemic neuronal injury. 
Synaptic transmission is based on the rapid exo­
cytosis of neurotransmitters from synaptic vesicles 
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(Katz， 1969). The SNARE hypothesis states that each 
class of transport vesicle contain a speεific targeting 
protein (v- or vesicle SNARE) that is capable of 
associating only with a receptor protein (t- or target 
SNARE) specilïc to the appropriate acceptor mem 
brane. The proteins hypothesized to serve as SNAREs 
at the synapse include the synaptic vesicle protein 
V AMP (vesicle-associated membrane protein， also 
called synaptobrevin) (Trimble et al， 1988; Baumert 
et al， 1989) and two plasma membrane proteins， 
syntaxin (also HPC-l) (Bennet et al， 1992; lnoue et 
al， 1992) and SNAP-25 (synapse-associated protein of 
25 kDa) (Oyler et al， 1989). Syntaxin， SNAP-25 and 
synaptobrevin form a trimeric complex referred to as 
the core synaptic complex. The complex is veη stable 
(Hayashi et al， 1994) and it serves as a binding site 
for N-ethylmaleimide-sensitive factor (NSF) and sol­
uble NSF-attachment protein (SNAP) which dissoci­
ate the complex by using energy from ATP hy­
drolysis (Hanson et al， 1992; Söller et al， 1993) 
Synapsin 1， a vesicle protein， may be to regulate 
vesicle availability， placing the liberation of vesicles 
from the cytoskeleton more tightly under the control 
of activated Ca2 -calmodulin-dependent (CaM) ki 
nase 11. So critical synapsin 1 lìmction occurs at a 
step between docking and fusion (Hirokawa et al， 
1989; Jessell & Kendal， 1993; Hicks et al， 1997) 
Evidence has been found that anoxiafischemia 
causes the release of various neurotransmitters by a 
Caι dependent and a Caι . -independent mechanism 
(Drejer et al， 1985; Kauppinen et al， 1988; lkeda et 
al， 1989). But there is no information regarding 
whether the release of monoamines is directly as 
sociated with synaptic vesicular proteins under is 
chemic con이t10ns 
Therefore this study was aimed to clarify the 
relationship between the release of 5-hydroxytrypta­
mine (5-HT) and synaptic vesicular protein under 
glucose and oxygen deprivation in rat hippocampal 
slices. Additionally， we tested that the release of 
5-HT and expression of vesicular proteins were 
mediated by the action of the glutamate receptor 
METHODS 
Preparation and maintenance 01 rat hippocampal 
slicεs 
Male Sprague-Dawley rats ( l 80�200 g) were 
used. Rat was decapitated and its brain was rapidly 
removed and disseεted on ice (Paschen & Djuricic， 
1995). Each hippocampus isolated from both sides of 
the brain was sliced transversely at 400 1，m with a 
tissue slicer (Stoelting Co.， Wood Dale， IL， USA) on 
에ter paper soaked in cold normal buffer (2 � 4 'c， 
95% Oz/5% CO2). The normal buffer solution con 
sisted of the following (mM): NaCl 124， KCl 4， 
CaCl， 2， KH2P04 1.25， NaHC03， 25， Glucose 10 
12.5 μM Nialamide (Sigma Chemical Company， St 
Louis， MO， USA)， monoamine oxidase inhibitor， was 
supplemented to prevent metabolization of 5-HT 
Hippocampal slices were divided into four group 
s1ices in normal buffer， slices in glucosefoxygen de 
privated (GOD) buffer， s1ices in normal buffer with 
DL-2-amino-5-phosphonovaleric acid (APV 30 μM， 
Research Biochemical Incorporated， Natick， MA， 
USA) and slices in GOD with APV 
Preparation 0/ glucose and oxygen deprivation and 
uptake 01 {'HJ5-HT 
After preparation， hippocampal slices were trans­
ferred to warrned 8 rnl normal buffer and slices were 
allowed to reζover from preparation stress for 30 min 
in a shaking water bath. Temperature of buffer was 
set to 370C throughout the experiments. After 30 
min-preincubation period， normal buffer was changed 
to buff，εr with 0.1 μM r3H]5-HT (74 μCif8 ml， 
Amersham pharrnacia biotech， Uppsala， Sweden) and 
slices were allowed to uptake ['H]5-HT in tissue 
sufficiently for 30 min. And then， buffer with ['H]5 
HT was discarded and slices were washed with 
normal buffer. Washed slices were randomly divided 
into 4 vials with 2 ml buffer solution with zimelidine 
(10 μM， Research Biochemical Incorporated， Natick， 
MA， USA)， 5-HT reuptake inhibitor. Buffer solutions 
were changed every 10 min during 120 min in 
cubation period. Glucosefoxygen deprivation (incuba­
tion of slices in glucose-free medium gassed with 
95% N2f5% CO，) was induced for 20 min at 50-min 
incubation step. 10 ml mannitol (Sigma Chemical 
Company， St. Louis， MO， USA) was added to glu­
cosefoxygen deprivated buffer instead of glucose for 
maintaining of same osm이arity. 30 μM APV， a 
NMDA receptor antagonist， was administrated si 
mu1taneously with GOD for 20 min 
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Counfing of radioactiviry 01 r-'H15-HT release USA) and SNAP-25 (Calvìochem， La J이la， CA， USA) 
lmmunoblots wcrc wash얘 tbrcc tîmcs in T、.vccn-Tris
bu[[crcd salinc (Tris 20 mM， NaCl 500 mM， 0.05% 
Tween-20)， and lhen incubaled [or 60 min wilh 
secondarγ antihodies ( 1  1000， anti-mouse IgG-POD， 
Fab fragmems， Boeringer mannheim， Basel， Switzer­
land). After washing with tris buffered saline ηris 20 
mM， NaCl 500 ml)， pro!cin bands wcrc visualizoo 
wiLh F매i medical X-ray fïhn by Enhanced chemili 
minescence method (Amersham Life Sciellce， Uppsala， 
Sweden). Density of pr，이eins on autoradiograrn wa이 
measured by den씨ometer. Proteins 이 시lces m 
nonnal buffer were assigned to 100% 
RESULTS 
r3Hj5-HT rdειse m llorm이 hllffer 
The hippocampal slice�、 、:howed spontaneom、 5-HT 
rclcasc tbroughout thc cxpcrimcnt. 5-HT rc1casc 
dCL'rcascd rapidly during lhc 디rsl 40 min， and lhcn 
a sleady release o[ 5-HT was observed up lo 120 mi끄 
Therefore， 5-HT rele‘ se at 5th 10-min period was 
used as a control and 이le changes of 5-HT release 
were expressed as percent values com‘ ared to the 
conlrol (Fig. 1 )  
500 μ1 o f  medium drained from the via 1 every 10 
min was mixed 、.vilh 5 ml o[ liquid scinlillalion 
cocktai1 (READY SAFE， Beckman lnstruments INC.， 
Fullerton， CA， USA). The radioreactivity of the mix 
hlre was counted with a liquid scinti1lation counter 
떠eckennan r씨ruments JNc.， Fullerton， CA， USA) 
T 0 measure thε radioreactivity of r1H15-HT 1εfr in the 
hippocampal slices， 비e tlssues 、.vere treated with 1 ml 
of tissue solubilizer (Lumasolve， Lumac LSC， Gro 
ningen， Netherlands) and incubated for 60 min. 1 1en 
100 μ1 of the completely s이ubi1ized sample was 
mixed with 5 ml of liquid scintillation cocktail for 
counting. Total radioactiviry of (H15-HT was sum of 
the radioactivity of eH]5-HT released into the media 
α시lected every 10 min from the given time fraction 
to the end of the observation κm잉 and the radio 
reactivity of r.l대5-HT remaining in hippocampal 
sliccs aftcr 120-min obscπation pcriocl. All thc rcsulrs 
of radiorcactivity rc1cascd into thc mcdia collcctcd 
during the given lO-min time fractiün were expressed 
as fractional release to tma1 radioreactity. After 
50-min period， the fraction release was stabilized and 
thcn pcrccnt of thc r’H15-HT rclcasc at 50-m  was 
assl믿.lcd as 100% 
Dala 、.vcrc cxprcsscd as mcan:t slandard CITor 
Statistica1 compansons among multi끼e group，、 were 
carried out using analysis 이 variances (ANOV A) 
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Fig. 1. Effeιts of glucüse!oxygen depriv“tion (GOD) “nd 
DL-2-amino-5-phosphonovalcric acid (APV) on lhc spon­
taneOllS release of r�H15-hydroxytrypt<lmine (HT) in the 
mt hipPlX:<lmal slicδ GOD was indllιeκ.1 for 20 min by 
changing glucose-free incubalion medillmaeraled wilh 
95% Nú5% CO� gas. V<llues <tre mean I S.E. express“ed 
<lS percent of the eH]5-HT rele“e <lt 50 minlltes‘ which 
was assinged as 100%. *p<0.05 compareκj 10 conlr이 
‘p <: 0.05 comp<lred to GOD wi th APV (Dllnnett meth에 
w“s llscd) 
"" “m ，。% 
ζτ응←)
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Hümogenates from 피ppocmnpal slices in eaιh 
group were anal ysed using gel electrophore�‘is (Pa 
tanow et al， 1997). Proteins (20 μg for synap，、in 1 ，  
5 μ g  for syntaxin and SNAP-25) wεre elecπo 
phorcscd using 30% acrylamidc gclsjBis solution 
(Bio-Rad Labormorics， Hcrculcs， CA， USA) and lolal 
protein concentration was determined llsing the meth 
od ()f Bradford (1976). Pnm히ns were transfeπed from 
the gels to nitrocellulose (Ame 이13m Pharmacia Bio­
tcch， Uppsala， Swαicn). Afrcr incubalcd ovcruighr in 
blocking solurion (5% skim milk in tris buffcrcd 
salinc‘ DIFCO Labor끼1oriccl， Dαroit， Ml， USA)‘ bl이S 
were allowed to react f{π 120 min with monoc1onal 
pnmarγ antihod.ie�、 (used at di1ution of 1 : 5(0) as 
fo11。、NS : synapsin 1 (Calbiocl삐11， La Jo11a， CA， USA)， 
syntaxin (Sigma Chcmical Company， Sr. Louis， MO， 
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Fig. 2. Expre‘don of synapsin 1 in glu.ιose{oxygen 
dcprivcd (OüD) mt hippocampal sliccs in thc prcscncc 
and absc'11{;(; of DL-2-amim←5-phosphonovalcrk aι d (APV) 
GOD was induιeπ:l flπ 20 min utes by ιhanging inwbation 
tncdiutn dcplctcd glucosc and acmtcd with 95% N:d5% 
CO2 gas. Aoovc: Rcprcscntativc WcstC1끼 b1야 analysis， 
Bdow: Dt:nsitomt:trk quantifk‘.ttion 
[’H]5-HT release in GOD 
When exposed to GOD for 20 min from 5th 10 
mm-pen얘， r3H]5-HT r리em\e was beginning to 
incrcasc from 6th 10 찌in pcriod and thcn showcd 
peak increase at 7th 10 min perk씨 After changing 
o[ nonnal buαer， l3HJ5-HT re1ease was no! di[[eren! 
with contr，이 (Fig. 1) 
('H]5-HT release by APV 
When treated with APV for 20 min f1"Om 5th 
lO-min pcriod‘ l’H J5-HT rclcasc was no1 di[[crclll 
from control leve1 (Fig. 1). When exposed to GOD 
wilh APV [01' 20 mi n， l"HJ5-HT re1ease was p때ially 
inhibited compared to r:ll-f)5-HT release of GOD only 
a1 71h lO-min period， and lhen values l'히umed ap 
proxunatεly to control level 
lνestern blot anaJ.vsis of synapsin J， synraxin and 
SNAP-25 
Amount of synapsin 1， \vhich is a synaptîc 
vesicular protein， increased in GOD and this increase 
、νas parlially inhibiLed by APV (F ig. 2). Bu! the 
amounts of ‘yntaxin and SNAP-25， which are plasma 
mcmbranc pr.이cins， dic띠’1 sh。、.v di[[crcnccs ap 
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Fig. 3. Expre‘、ion of syntaxin in gllH:os비oxygen deprived 
(OOD) rat hip1Xιampal 이kes in the presence and 
"b‘cncc of DL-2-amino-5-phosphcηlOva\cric acid (APV) 









Fi잉. 4. Expression of SNAP-25 in glucoseJoxygen de 
prived (GOD) rat hippocampal sliιes in the presence and 
absence of DL-2-amino-5 띠lOsphonovalelic aιid (APV) 
Other legends are the same as Fig. 2 
DISCUSSION 
Because the ischemia ι detïned as a reduction in 
cerebral blα애 tlow of sufficient severity to cause 
mctabolic dcficits (Sicsjμ 1984)， it sccms (to bc) that 
the condition of gluc씨e and oxygen deprivation 
(GOD) is closc LO UIC mcaning o[ ischcmia in vivo 
In this study， r3H]5-HT release markedly increased 
by GOD and thc incrcasc of rclcasc was inhibitcd 
pattial ly by NMDA receptor antagonist， APV. This 
indicaLes 1hat aclÎvalion o[ NMDA receplor may be 
involved in 대e mechanism of r3H]5-HT release 
during ischemia. The relationship between 5-HT re 
lease and glutamate receptor ha‘ been shown by some 
olher reporlS. Ohta e1 a1 (1994) repor1ed lhaL presy 
napt:J.c lon이ropic glutmnate receptors exist 011 5-HT 
teπninals in the rat ‘ttiatum a1띠 their subtypes 
equally contributed to facìlìtaring 5-HT release by 
expe끼mem of microdialysis in vivo. Fink et al (1995) 
showcd that activation of NMDA or non-NMDA 
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receptors elicited a release of 5-HT in rat brain cortex 
slices. So， uninhibited portion of 5-HT release in this 
study may be related to activation of non-NMDA 
receptor or Ca�+ -independent release 
Our goal of the present study was to evaluate that 
the release of r3H]5-HT during GOD was related to 
synaptic vesicular protein. We have observed that 
expression of synapsin 1 increased with GOD and the 
increase was partially inhibited by APV but those of 
syntaxin and SNAP-25 didn’t show apparent change 
Several studies show that neurotransmitter-related 
proteins are increased after ischemia in vivo. ln 
creased expression of synaptophysin in rat striatum 
(Korematsu et al， 1993)， SVP-38 (synapsin 1 and 
synaptophysin) in gerbil forebrain (Miyazawa et al， 
1995) and SNAP-25 in the hippocampus of gerbil 
(Martí et al， 1998) after ischentia were showed by 
immunoreactivity. But their reports provide only the 
evidence of involvement of these proteins in tissue 
injury after ischentia but did not mentioned the 
relationship with release of neurotransmitter during 
ischemia 
In this study， the pattem of change of synapsin 1 
on GOD was similar to that of r3H]5-HT release 
A1though exocytosis is inhibited after few minutes of 
ischemia because synaptic vesicle release is calcium 
and ATP dependent (Sanchez-Prieto & Gonçalez， 
1988; Nicholls， 1989)， these results suggest that syn 
apsin 1 is involved in the release of neurotransmitter 
during ischemia. Synapsin 1 is believed to regulate 
the number of vesicles available for release by 
reversibly anchoring them to the actin-based cyto 
skeletal matrix of the presynaptic nerve tenninals 
(Bähler et al， 1990; Linás et al， 1991; Greengard et 
al， 1993). This vesicle-anchoring property is regulated 
by the phosphorylation state of synapsin 1. The 
interaction of synapsin 1 both with vesicles and with 
actin are reduced upon its phosphorylation by CaM 
kinase II (Schiebler et al， 1986; Bähler & Greengard， 
1987). So apparent increase of synapsin 1 other than 
syntaxin and SNAP-25 during GOD may be related 
with activation of Caκ1 kinase II by Ca2 inllux. In 
addition (to)， the synapsin constitute a high percen 
tage of the synaptic vesicle membrane-bound protein 
fractÎon so r‘elatively large amount of synapsin 1 may 
be an another factor 
Because the increased expression of synapsin 1 was 
P따tially inhibited by APV in GOD， expression of 
synapsin 1 may be regulated by NMDA receptor in 
part. Fukunaga et al (1992) r 
can activate CaM kinase II through the ionotrophic 
NMDA receptor， which in tum increase the phos­
phorylation of nticrotuble-assocÎated protein 2 and 
synapsin 1. And Katchman & Hershkowitz (1997) 
suggested that NMDA receptor-activated nitric oxide 
(NO) production may enhance vesicular synaptic glu 
tamate release， which would in tum contribute to 
excitotoxicity during hypometabolic states 
Evidences have been found that ischemia causes 
the release of various neurotransmitters by a cl+ 
independent mechanism (Sanchez-Prieto & Gonçalex， 
1988; lkeda et al， 1989). And several studies have 
shown that the Ca'+ -independent component of the 
lschemia-induced release of neurotransmiters may be 
due to the reversal of Na -dependent neurotransmitter 
caπ;ers， as a resuJt of the a1teration in intracellular 
ions occurring during ATP depletion (Erecinska & 
Silver， 1994). So further investigation is required to 
test which mechanism is related to the release of 
neurotransmitter during ischemia by control of Ca � + 
or CaM kinase II 
ln summary， we showed that the release of 
r3H]5-HT and the expression of synapsin 1 increased 
Sl망1ilïcantly during GOD πlese increases were 
inhibited partially by an NMDA receptor antagonist， 
so we suggested that the mechanism of CH]5-HT 
release during GOD is associated with synapsin 1 via 
activation of NMDA receptor in p야[ 
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